Introduction: Elevated intraocular pressure (IOP) remains the most important modifiable risk factor in the progression of open-angle glaucoma (OAG) and ocular hypertension (OHT) (1). Despite multiple therapeutic options, limitations persist with existing agents such as β-blockers (e.g., timolol), including systemic side effects, variable efficacy a
51 Reached1 Comments
Safe Ramadan Practices during COVID-19 - WHO Guidance
6567 Reached8 Comments3 Likes
How Physicians Should Manage Stress?
35340 Reached151 Comments202 Likes
Managing Meconium Aspiration Syndrome in Infants
9817 Reached7 Comments8 Likes
Infant with Congenital Diaphragmatic Hernia (CDH)
6995 Reached14 Comments8 Likes
Woman presented with Fever of Unknown Origin
7747 Reached93 Comments19 Likes